![Meeting](https://tspot.asia/wp-content/uploads/2020/02/Meeting-1400x420.jpg)
![Meeting](https://tspot.asia/wp-content/uploads/2020/02/Meeting-1400x420.jpg)
The risk of progression from Latent TB infection (LTBI) to active TB is higher amongst immunocompromised patients — who are they? Webinar covers an update on TB testing methods amongst immunocompromised patients and the clinical utility of IGRAs in this patient population group.
Posted in Recorded Webinar